Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
”Myeloma Paper of the Day:
Anti-BCMA immunotherapies deplete plasmacytoid dendritic cells and impair antiviral immunity in myeloma leading to high burden of predominantly low‐grade respiratory viral infections, which significantly impair QOL.
Title: Anti-BCMA immunotherapies deplete plasmacytoid dendritic cells and impair antiviral immunity in multiple myeloma
Authors: Ondrej Venglar, Eva Radova, Maxima Warmuzova, Daniel Bilek, Marketa Kudelkova, Katerina Jasinkova, Ludmila Muronova, Lucie Broskevicova, Veronika Kapustova, Jan Vrana, Tereza Novakova, Katerina Karasova, Michaela Hornakova, Tereza Popkova, Jana Mihalyova, Hana Plonkova, Michal Simicek, Jakub Radocha, Tereza Sevcikova, David Zihala, Juli Bago, Roman Hajek, Tomas Jelinek
You can read the full article on WILEY Online Library.

You can find other articles featuring Robert Orlowski on OncoDaily.